Acetylcholine-mediated modulation of striatal function

Trends in Neurosciences

Volumn 23, Issue 3, 2000, Pages 120-126

  Calabresi, Paolo ^a   Centonze, Diego ^a   Gubellini, Paolo ^a,b   Pisani, Antonio ^a   Bernardi, Giorgio ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CNR   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; MUSCARINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; OXOTREMORINE;

BASAL GANGLION; BRAIN FUNCTION; BRAIN NERVE CELL; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CORPUS STRIATUM; ELECTROPHYSIOLOGY; INTERNEURON; LONG TERM POTENTIATION; MOTOR DYSFUNCTION; NERVE PROJECTION; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ACETYLCHOLINE; ANIMALS; CELLS, CULTURED; CORPUS STRIATUM; EXCITATORY AMINO ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; LONG-TERM POTENTIATION; N-METHYLASPARTATE; NERVE NET; RATS; RECEPTORS, MUSCARINIC; SYNAPTIC TRANSMISSION;

EID: 0034161289     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(99)01501-5     Document Type: Review

References (54)

1. Weiner D.M.et al. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc. Natl. Acad. Sci. U. S. A. 87:1990;7050-7054.
2. Hersch S.M.et al. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J. Neurosci. 14:1994;3351-3363.
3. Graybiel A.M.et al. The basal ganglia and adaptive motor control. Science. 265:1994;1826-1831.
4. Barbeau A. The pathogenesis of Parkinson's disease: a new hypothesis. Can. Med. Assoc. J. 87:1962;802-807.
5. Lehmann J., Langer S.Z. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals? Neuroscience. 10:1983;1105-1120.
6. Stoof J.C.et al. Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience. 47:1992;755-770.
7. Di Chiara G.et al. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17:1994;228-233.
8. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
9. Lindefors N., Ungerstedt U. Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons. Neurosci. Lett. 115:1990;248-252.
10. Ingham C.A.et al. Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway. Exp. Brain Res. 93:1993;17-27.
11. Anglade P.A.et al. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration. 5:1996;121-128.
12. Calabresi P.et al. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain. 116:1993;433-452.
13. Blanchet P.J.et al. Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease. Neurosci. Biobehav. Rev. 21:1997;447-453.
14. Lange K.W.et al. Dopamine/glutamate interactions in Parkinson's disease. Neurosci. Biobehav. Rev. 21:1997;393-400.
15. Gossel M.et al. Effect of coadministration of glutamate receptor antagonists and dopaminergic agonists on locomotion in monoamine-depleted rats. J. Neural Transm. 10:1995;27-39.
16. Carroll C.B.et al. Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms. Psychopharmacology. 119:1995;55-65.
17. Chase T.N.et al. Neostriatal mechanisms in Parkinson's disease. Neurology. 51:1998;S30-S35.
18. Stern E.A.et al. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo. Nature. 394:1998;475-478.
19. Calabresi P.et al. The corticostriatal projection: from synaptic plasticity to basal ganglia disorders. Trends Neurosci. 19:1996;19-24.
20. Woolf N.J., Butcher L.L. Cholinergic neurons in the caudate-putamen complex proper are intrinsically organized: a combined Evans blue and acetylcholinesterase analysis. Brain Res. Bull. 7:1981;487-507.
21. Woolf N.J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
22. Woolf N.J., Butcher L.L. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res. Bull. 16:1986;603-637.
23. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;133-154.
24. Wilson C.J.et al. Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum. J. Neurosci. 10:1990;508-519.
25. Izzo P.N., Bolam J.P. Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat. J. Comp. Neurol. 269:1988;219-234.
26. Kawaguchi Y.et al. Striatal interneurons: chemical, physiological and morphological characterization. Trends Neurosci. 18:1995;527-535.
27. Freund T.F.et al. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience. 13:1984;1189-1215.
28. Chang H.T. Dopamine-acetylcholine interaction in the rat striatum: a dual-labeling immunocytochemical study. Brain Res. Bull. 21:1988;295-304.
29. Kubota Y.et al. Neostriatal cholinergic neurons receive direct synaptic inputs from dopaminergic axons. Brain Res. 413:1987;179-184.
30. Lapper S.R., Bolam J.P. Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroscience. 51:1992;533-545.
31. Contant C.et al. Ultrastructural characterization of the acetylcholine innervation in adult rat neostriatum. Neuroscience. 71:1996;937-947.
32. Sugita S.et al. Distinct muscarinic receptors inhibit release of GABA and excitatory amino acids in mammalian brain. Proc. Natl. Acad. Sci. U. S. A. 88:1991;2608-2611.
33. Bonner T.I.et al. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-532.
34. Bonner T.I. The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12:1989;148-151.
35. Hulme E.C.et al. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30:1990;633-673.
36. Andersen D.J., McKinney M. Muscarinic M2 receptor mediated cAMP reduction in mechanically dissociated rat cortex. Brain Res. 475:1988;28-34.
37. Bernard V.et al. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12:1992;3591-3600.
38. Hsu K.-S.et al. Carbachol induces inward current in neostriatal neurons through M1-like muscarinic receptors. Neuroscience. 73:1996;751-760.
39. Calabresi P.et al. Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation. Eur. J. Neurosci. 10:1998;2887-2895.
40. Akins P.T.et al. Muscarinic modulation of the transient potassium current in rat neostriatal neurones. Nature. 344:1990;240-242.
41. Misgeld U.et al. Muscarinic modulation of calcium-dependent plateau potentials in the rat neostriatal neurons. Pflügers Arch. Physiol. 407:1986;482-487.
42. Howe A.R., Surmeir D.J. Muscarinic receptors modulate N-, P-, and L-type calcium currents in rat striatal neurons through parallel pathways. J. Neurosci. 15:1995;458-469.
43. James M.K., Cubeddu L.X. Pharmacological characterization and functional role of muscarinic autoreceptors in the rabbit striatum. J. Pharmacol. Exp. Ther. 240:1987;203-215.
44. 2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway. J. Neurosci. 16:1996;2592-2604.
45. Calabresi P.et al. Muscarinic IPSPs in rat striatal cholinergic interneurones. J. Physiol. 510:1998;421-427.
46. Richelson E. Cholinergic transduction. Bloom F.E., Kupfer D.J. Psycopharmacology: The Fourth Generation of Progress. 1995;125-134 Raven Press.
47. Ben-Ari Y.et al. Protein kinase C modulation on NMDA currents: an important link for LTP induction. Trends Neurosci. 15:1992;333-339.
48. Bernardi G.et al. The action of acetylcholine and L-glutamic acid on rat caudate neurons. Brain Res. 114:1976;134-138.
49. Takagi M., Yamamoto C. Suppressing action of cholinergic agents on synaptic transmission in the corpus striatum of rats. Exp. Neurol. 62:1978;433-443.
50. Dodt H.U., Misgeld U. Muscarinic slow excitation and muscarinic inhibition of synaptic transmission in the rat neostriatum. J. Physiol. 380:1986;593-608.
51. Akaike A.et al. Muscarinic inhibition as a dominant role in cholinergic regulation of transmission in the caudate nucleus. J. Pharmacol. Exp. Ther. 246:1988;1129-1136.
52. Calabresi P.et al. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. Eur. J. Neurosci. 10:1998;3020-3023.
53. Calabresi P.et al. Long-term potentiation in the striatum is unmasked by removing the voltage-dependent blockade of NMDA receptor channel. Eur. J. Neurosci. 4:1992;929-935.
54. Calabresi P.et al. Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP. Neuropharmacology. 38:1999;323-326.